The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment
This study constructs a systems biology model to investigate how tumor receptor heterogeneity affects responses to combination anti-angiogenic therapy in cancer patients.
Integrative Biology · Apr 1, 2018Peer-reviewedSystems Biology